In one paragraphArticle in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Lannah S AbasiDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA.
Challana TeaDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA.
Donald LeDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
Funding
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0MMolecular Biophysics Training Grant at UC San DiegoT32GM139795 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Galia Debelouchina, ELIZABETH A. KOMIVES · 2021 to 2026
$3.0MStructural biology of chromatin in vitro and in cellsR35GM138382 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Galia Debelouchina · 2020 to 2026
$2.8MUC San Diego Genetics Training ProgramT32GM145427 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRUCE A HAMILTON · 2022 to 2026
$2.6MMultiscale Computational Models to Investigate the Role of Phase Separation in BiologyR35GM153388 · NIGMS · TEXAS ENGINEERING EXPERIMENT STATION · PI Jeetain Mittal · 2024 to 2026
$1.3MRegulation of phase separation in neuronal heterochromatinR01NS138924 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Cole John Ferguson · 2024 to 2026
$941kAcquisition of an Orbitrap Elite with ETDS10OD021724 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 2016 to 2016
$600kIllumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600kMultiscale Computational Models of Heterochromatin Phase SeparationK99GM159055 · NIGMS · TEXAS ENGINEERING EXPERIMENT STATION · PI Tien Minh Phan · 2026 to 2026
$135kU.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) K99GM159055U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM138382U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM153388U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM139795U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM145427U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) P30NS047101U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS138924U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) S10OD021724U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) S10OD026929
6 · The paper itselfAbstract
The dysregulation of chromatin organization has been associated with numerous forms of neurological disease. In the ANAPC7 neurodevelopmental syndrome, a disease mechanistically linked to defective proteasomal degradation, the mitotic protein Ki-67 accumulates abnormally in heterochromatin compartments. Here, we investigate Ki-67's role in heterochromatin through in vivo examination of neurons from two relevant genetic mouse models, in vitro assays and computational studies. We find that Ki-67 modulates the size and number of heterochromatin compartments in neurons. Furthermore, we demonstrate that an engineered Ki-67 construct enhances the propensity of HP1α and nucleosome arrays to form condensates in vitro, a process that is mediated through a complex network of electrostatic interactions and is robust to relevant histone post-translational modifications. These observations suggest that Ki-67 may regulate heterochromatin through a phase separation mechanism involving additional heterochromatin components, thus providing insights into the roles of Ki-67 during both typical neurodevelopment and in disease.
Indexed as
HeterochromatinKi-67 AntigenNeuronsAnimalsChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHistonesHumansMiceNucleosomesPhase SeparationProtein Processing, Post-TranslationalChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHeterochromatinHistonesKi-67 AntigenNucleosomes
What OpenQuestion holds
Textmetadata
Read underepoch 390